论文信息 - Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT - 字舞流文

Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT

Yong Yang | Yijun Chen | Tingting Cui | Xingyi Chen | Duo Chen | Hongbao Yang | Nadia Kabir | Jinyan Ma | P. Pan | Jie Mao